According to a Pharmacy Times article by TRHC’s Veronique Michaud, BPharm, PhD, opioid overdoses can stem from adverse drug events caused by drug-gene or multi-drug-gene interactions. By leveraging pharmacogenomic testing with advanced medication decision support tools that provide simultaneous multidrug analysis, pharmacists can better evaluate how a patient might metabolize and examine how other medications might further impact this metabolism.
As Dr. Michaud points out in the article, pharmacists can play a critical role in reducing unintended overdoses from prescription opioids, with help from advanced medication decision support.
Share this: